Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent Claudication

Rosas, Guillermo; Cerdeyra, Cristina; Lucas, Miguel A.; Parano, Jorge R.; Villa, Juan J.
May 1981
Angiology;May1981, Vol. 32 Issue 5, p291
Academic Journal
In a group of 58 patients with peripheral arteriopathies, we have studied efficacy and safety of buflomedil hydrochloride and naftidrofuryl. Both drugs have been shown to have vasoactive properties evaluated through walking capacity and time of hyperemia. According to our results, buflomedil is more effective and safe than naftidrofuryl in the treatment of patients with intermittent claudication.


Related Articles

  • Treatment of intermittent claudication. Karthikeyan, G.; Eikelboom, John W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p671 

    The authors reflect on methods which are used to treat intermittent claudication. They suggest that any methods that are used should improve the patient's symptoms and decrease the risk of cardiovascular problems. They argue that the most important goal of medical treatment in patients with...

  • Intermittent claudication due to right common femoral artery compression by a solitary neurofibroma. Pulathan, Zerrin; Imamoglu, Mustafa; Cay, Ali; Güven, Yasar Kibar // European Journal of Pediatrics;Jul2005, Vol. 164 Issue 7, p463 

    Examines the case of a 10-year-old girl with slowly progressive intermittent claudication (IC) in her right calf. Background information on IC; Physical examination of the patient; Causes of IC.

  • Comparative Evaluation of Pentoxifylline, Buflomedil, and Nifedipine in the Treatment of Intermittent Claudication of the Lower Limbs. Chacón-Quevedo, A.; Eguaras, M. G.; Calleja, F.; Garcia, M. A.; Roman, M.; Casares, J.; Muñoz, I.; Concha, M. // Angiology;Jul1994, Vol. 45 Issue 7, p647 

    In the light of the current controversy surrounding the use of hemorheologic and vasodilator drugs in the treatment of peripheral arteriosclerosis, a comparative study was designed in order to evaluate the efficacy of pentoxifylline, buflomedil, and nifedipine in 45 patients with peripheral...

  • Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651 

    Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...

  • Naftidrofuryl: A Review of its Use in the Treatment of Intermittent Claudication. Goldsmith, David R.; Wellington, Keri // Drugs & Aging;2005, Vol. 22 Issue 11, p967 

    Naftidrofuryl (Praxilene®) is a vasodilator that has been used in the treatment of intermittent claudication for >30 years in Europe to improve walking distance and provide symptomatic relief. However, earlier trials had inconsistencies in design and the clinical relevance of the treatment...

  • Pentoxifylline for Intermittent Claudication. Ernst, E. // Angiology;May1994, Vol. 45 Issue 5, p339 

    Pentoxifylline was first introduced in Germany twenty years ago. Today it is the best researched oral drug for intermittent claudication. A total of seventeen placebo-controlled trials could be retrieved from the world literature. The majority of these studies show that pentoxifylline will...

  • LONG-TERM ANTICOAGULANT THERAPY IN THE TREATMENT OF INTERMITTENT CLAUDICATION. Milnés-López, Bernardo; Carrillo, Pedro; Toledo, Fernando; McCook, George // Angiology;Dec1957, Vol. 8 Issue 6, p534 

    Discusses the long-term anticoagulant therapy in the treatment of intermittent claudication. Evaluation of intermittent claudication; Effect of long continued anticoagulant therapy on intermittent claudication; Degree of improvement of the treatment.

  • INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S. // Angiology;Aug1958, Vol. 9 Issue 4, p245 

    Provides information about intermittent claudication. Cause and pathogenesis; Signs and symptoms; Diagnosis and treatment;

  • Community trial of home-based exercise therapy for intermittent claudication. Mouser, Matthew J.; Zlabek, Jonathan A.; Ford, Catherine L.; Mathiason, Michelle A. // Vascular Medicine;2009, Vol. 14 Issue 2, p103 

    Peripheral arterial disease (PAD) is a common disease, and intermittent claudication (IC) is a life-changing symptom. Exercise therapy has been demonstrated to be an effective treatment for IC in a supervised setting; however, most insurance carriers do not reimburse for exercise therapy. As a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics